会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • HIV INHIBITING 5-SUBSTITUTED PYRIMIDINES
    • 艾滋病毒抑制5-取代的吡咯烷酮
    • WO2006035069A1
    • 2006-04-06
    • PCT/EP2005/054932
    • 2005-09-29
    • TIBOTEC PHARMACEUTICALS Ltd.GUILLEMONT, Jerôme, Emile, GeorgesHEERES, JanLEWI, Paulus Joannes
    • GUILLEMONT, Jerôme, Emile, GeorgesHEERES, JanLEWI, Paulus Joannes
    • C07D239/48C07D239/50A61K31/505A61P31/18
    • C07D239/48C07D239/50
    • HIV replication inhibitors of formula (I) a N -oxide, a pharmaceutically acceptable addition salt, a quaternary amine or a stereochemically isomeric form thereof, wherein A is -CH 2 -CH 2 - , -CH=CH- , -C≡C- ; R 1 is hydrogen, aryl, formyl, C 1-6 alkylcarbonyl, C 1-6 alkyl, C 1-6 alkyloxycarbonyl, R 2 hydroxy, halo, C 1-6 alkyl, carboxyl, cyano, -C(=O)R 6 , nitro, amino, mono- or di(C 1-6 alkyl)amino, polyhalomethyl; X 1 is -NR 1 -, -O-, -S-, -S(=O) p- ; R 3 is H, C 1-6 alkyl, halo ; R 4 is H, C 1-6 alkyl, halo ; R 5 is nitro, amino, mono- and diC 1-4 alkylamino, aryl, halo, -CHO, -CO-R 6 , -COOR 7 , -NH-C(=O)H, -NH-C(=O)R 6 , -CH=N-O-R 8 ; R 6 is C 1-4 alkyl, amino, mono- or di(C 1-4 alkyl)amino or polyhaloC 1-4 alkyl; R 7 is hydrogen, C 1-6 alkyl, arylC 1-6 alkyl; R 8 is hydrogen, C 1-6 alkyl, aryl; p is 1 or 2; aryl is optionally substituted phenyl; pharmaceutical compositions containing these compounds as active ingredient and processes for preparing said compounds and compositions.
    • 式(I)的HIV复制抑制剂N-氧化物,药学上可接受的加成盐,季胺或其立体化学异构体形式,其中A为-CH 2 -CH 2, , - CH = CH - , - C = C-; R 1是氢,芳基,甲酰基,C 1-6烷基羰基,C 1-6烷基,C 1-6烷基, 烷基氧基羰基,R 2羟基,卤素,C 1-6烷基,羧基,氰基,-C(= O)R 6, ,硝基,氨基,一或二(C 1-6烷基)氨基,多卤代甲基; X 1是-NR 1 - , - O - , - S - , - S(= O)p - 。 R 3是H,C 1-6烷基,卤素; R 4是H,C 1-6烷基,卤素; R 5是硝基,氨基,单和二C 1-4烷基氨基,芳基,卤素,-CHO,-CO-R 6, -COOR 7,-NH-C(= O)H,-NH-C(= O)R 6,-CH = NOR 8 >; R 6是C 1-4烷基,氨基,单或二(C 1-4烷基)氨基或多卤代1 -4 烷基; R 7是氢,C 1-6烷基,芳基C 1-6烷基; R 8是氢,C 1-6烷基,芳基; p为1或2; 芳基是任选取代的苯基; 含有这些化合物作为活性成分的药物组合物和制备所述化合物和组合物的方法。
    • 3. 发明申请
    • AMINO-BENZIMIDAZOLES DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION
    • 氨基苯并咪唑衍生物作为呼吸道同种病毒复制的抑制剂
    • WO2005058870A1
    • 2005-06-30
    • PCT/EP2004/053617
    • 2004-12-20
    • TIBOTEC PHARMACEUTICALS LTD.BONFANTI, Jean-FrançoisANDRIES, Koenraad, Jozef, LodewijkJANSSENS, Frans, EduardSOMMEN, François, MariaGUILLEMONT, Jerôme, Emile, GeorgesLACRAMPE, Jean, Fernand, Armand
    • BONFANTI, Jean-FrançoisANDRIES, Koenraad, Jozef, LodewijkJANSSENS, Frans, EduardSOMMEN, François, MariaGUILLEMONT, Jerôme, Emile, GeorgesLACRAMPE, Jean, Fernand, Armand
    • C07D401/06
    • C07D405/14C07D401/06C07D401/14
    • The present invention concerns amino-benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formula (I) their prodrugs, N -oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms wherein Q is Ar 1 or C 1-6 alkyl substituted with one or more substituents selected from trifluoromethyl, C 3-7 cycloalkyl, Ar 2 , hydroxy, C 1-4 alkoxy, C 1-4 alkylthio, Ar 2 -oxy-, Ar 2 -thio-, Ar 2 (CH2)„oxy, Ar 2 (CH 2 ) n thio, hydroxycarbonyl, aminocarbonyl, C 1-4 alkylcarbonyl, Ar 2 carbonyl, C 1-4 alkoxycarbonyl, Ar 2 (CH 2 ) n carbonyl, aminocarbonyloxy, C 1-4 alkylcarbonyloxy, Ar 2 carbonyloxy, Ar 2 (CH 2 ) n carbonyloxy, hydroxy-C 2- 4 -alkyloxy, C 1-4 alkoxycarbonyl(CH 2 ) n oxy, mono­or di(C 1-4 alkyl)-aminocarbonyl, mono- or di(C 1-4 alkyl)aminocarbonyloxy, aminosulfonyl, mono- or di(C 1-4 alkyl)aminosulfonyl, dioxolanyl optionally substituted with one or two C 1-6 alkyl radicals, and a heterocycle selected from pyrrolidinyl, pyrrolyl, dihydropyrrolyl, thiazolidinyl, imidazolyl, triazolyl, piperidinyl, homopiperidinyl, piperazinyl, pyridyl and tetrahydropyridyl, which each may optionally be substituted with oxo or C 1 - 6 alkyl; G is a direct bond or optionally substituted C 1-10 alkanediyl R 1 is Ar 1 or a monocyclic or bicyclic heterocycle; one of R 2a and R 3a is C 1-6 alkyl and the other one of R 2 a and R 3a is hydrogen; in case R 2 a is different from hydrogen then R 2b is hydrogen or C 1-6 alkyl, and R 3b is hydrogen; in case R 3a is different from hydrogen then R 3b is hydrogen or C 1-6 alkyl, and R 2b is hydrogen; Ar 1 is phenyl or substituted phenyl and Ar 2 is phenyl or substituted phenyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.
    • 本发明涉及对呼吸道合胞病毒复制具有抑制活性的氨基苯并咪唑,其具有式(I)的前药,N-氧化物,加成盐,季胺,金属络合物和立体化学异构形式,其中Q为Ar1或C1 被一个或多个选自三氟甲基,C 3-7环烷基,Ar 2,羟基,C 1-4烷氧基,C 1-4烷硫基,Ar 2 - 氧基 - ,Ar 2 - 硫基 - ,Ar 2 (CH2)“氧基,Ar2(CH2)nthio,羟基羰基,氨基羰基,C1-4烷基羰基,Ar2羰基,C1-4烷氧基羰基,Ar2(CH2)n羰基,氨基羰基氧基,C1-4 烷基羰基氧基,Ar 2羰基氧基,Ar 2(CH 2)n - 羰基氧基,羟基-C 2 - 4-烷氧基,C 1-4烷氧基羰基(CH 2)n羟基,一或二(C 1-4烷基) - 氨基羰基,单或二 1-4烷基)氨基羰基氧基,氨基磺酰基,一或二(C 1-4烷基)氨基磺酰基,任选被一个或两个C 1-6烷基取代的二氧戊环,以及选自吡咯烷基,吡咯基,二氢 吡咯基,噻唑烷基,咪唑基,三唑基,哌啶基,高哌啶基,哌嗪基,吡啶基和四氢吡啶基,其各自可以任选被氧代或C 1-6烷基取代; G是直接键或任选取代的C 1-10烷二基R 1是Ar 1或单环或双环杂环; R 2a和R 3a之一是C 1-6烷基,R 2 a和R 3a中的另一个是氢; 在R 2不同于氢的情况下,R 2b是氢或C 1-6烷基,R 3b是氢; 在R 3a不同于氢的情况下,R 3b是氢或C 1-6烷基,R 2b是氢; Ar 1是苯基或取代的苯基,Ar 2是苯基或取代的苯基。 它还涉及它们的制备方法和包含它们的组合物,以及它们作为药物的用途。
    • 6. 发明申请
    • HIV INHIBITING 5-HETEROCYCLYL PYRIMIDINES
    • 艾滋病毒抑制5-杂环亚氨基嘧啶
    • WO2006035067A2
    • 2006-04-06
    • PCT/EP2005/054930
    • 2005-09-29
    • TIBOTEC PHARMACEUTICALS LTD.GUILLEMONT, Jerôme, Emile, GeorgesHEERES, JanLEWI, Paulus, Joannes
    • GUILLEMONT, Jerôme, Emile, GeorgesHEERES, JanLEWI, Paulus, Joannes
    • C07D401/04C07D403/04C07D405/04C07D409/04C07D413/04C07D413/14
    • C07D405/04C07D401/04C07D403/04C07D409/04C07D413/04C07D413/14C07D417/04
    • HIV replication inhibitors of formula (I), N -oxides, pharmaceutically acceptable addition salts, quaternary amines or stereoisomeric forms thereof, wherein -a 1 =a 2 -a 3 =a 4 - is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, -N=CH-CH=N-, -N=N-CH=CH-; -b 1 =b 2 -b 3 =b 4 - is -CH=CH-CH=CH-, -N=CH-CH=CH-, -N=CH-N=CH-, -N=CH-CH=N-, -N=N-CH=CH-; R 1 is hydrogen; aryl; formyl; C 1-6 alkylcarbonyl; optionally substituted C 1-6 alkyl; C 1-6 alkyloxycarbonyl; R 2 is OH; halo; optionally substituted C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl; substituted carbonyl; carboxyl; CN; nitro; amino; substituted amino; polyhalomethyl; polyhalomethylthio; -S(=O) P R 6 ; C(=NH)R 6 ; R 2a is CN; amino; substituted amino; optionally substituted C1-6alkyl; halo; optionally substituted C 1-6 alkyloxy; substituted carbonyl; -CH=N-NH-C(O)-R 16 ; optionally substituted C 1-6 alkyloxyC 1-6 alkyl; substituted C 2-6 alkenyl or C 2-6 alkynyl; -C(=N-O-R 8 )-C 1-4 alkyl; R 7 or -X 3 -R 7 ; X 1 is -NR 1 -, -O-, -C(=O)-, -CH 2 -, -CHOH-, -S-, -S(=O) P - R 3 is CN; amino; C 1-6 alkyl; halo; optionally substituted C 1-6 alkyloxy; substituted carbonyl; -CH=N-NH-C(O)-R 16 ; substituted C 1-6 alkyl; optionally substituted C 1-6 alkyloxyC 1-6 alkyl; substituted C 2-6 alkenyl or C 2-6 alkynyl; -C(=N-O-R 8 )-C 1-4 alkyl; R 7 ; -X 3 -R 7 ; R 4 is halo; OH; optionally substituted C 1-6 alkyl, C 2-6 alkenyl or C 2-6 alkynyl; C 3-7 cycloalkyl; C 1-6 alkyloxy; CN; nitro; polyhaloC 1-6 alkyl; polyhaloC 1-6 alkyloxy; substituted carbonyl; formyl; amino; mono- or di(C 1-4 alkyl)amino or R 7 ; R 5 is a 5- or 6-membered completely unsaturated ring system wherein 1 - 4 ring members are nitrogen, oxygen or sulfur; which ring may optionally be substituted and may optionally be annelated with a benzene ring; methods for their preparation and pharmaceutical compositions comprising them. The invention also relates to the use of these compounds for the prevention or the treatment of HIV infection.
    • 式(I)的HIV复制抑制剂,
    • 7. 发明申请
    • PIPERIDINE-AMINO-BENZIMIDAZOLE DERIVATIVES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION
    • 作为呼吸道同种病毒复制的抑制剂的哌啶 - 氨基苯并咪唑衍生物
    • WO2005058873A1
    • 2005-06-30
    • PCT/EP2004/053606
    • 2004-12-20
    • TIBOTEC PHARMACEUTICALS LTD.BONFANTI, Jean-FrançoisANDRIES, Koenraad, Jozef, LodewijkJANSSENS, Frans, EduardSOMMEN, François, MariaGUILLEMONT, Jerôme, Emile, GeorgesLACRAMPE, Jean, Fernand, Armand
    • BONFANTI, Jean-FrançoisANDRIES, Koenraad, Jozef, LodewijkJANSSENS, Frans, EduardSOMMEN, François, MariaGUILLEMONT, Jerôme, Emile, GeorgesLACRAMPE, Jean, Fernand, Armand
    • C07D401/14
    • C07D401/14C07D417/14
    • The present invention concerns piperidine-amino-benzimidazoles having inhibitory activity on the replication of the respiratory syncytial virus and having the formula (I) their prodrugs, N -oxides, addition salts, quaternary amines, metal complexes and stereochemically isomeric forms wherein Q is C 1-6 alkyl optionally substituted with trifluorornethyl, C 3-7 cycloalkyl, Ar 2 , hydroxy, C 1-4 alkoxy, C 1-4 alkylthio, Ar 2 -oxy-, Ar 2 -thio-, Ar 2 (CH 2 ) n oxy, Ar 2 (CH 2 ) n thio, hydroxycarbonyl, aminocarbonyl, C 1-4 alkyl­carbonyl, Ar 2 carbonyl, C 1-4 alkoxycarbonyl, Ar 2 (CH 2 ) n carbonyl, aminocarbonyloxy, C 1-4 alkylcarbonyloxy, Ar 2 carbonyloxy, Ar 2 (CH 2 ) n carbonyloxy, C 1-4 alkoxy­ carbonyl(CH 2 ) n oxy, mono- or di(C 1-4 alkyl)aminocarbonyl, mono- or di(C 1-4 alkyl)-­aminocarbonyloxy, aminosulfonyl, mono-odi(C 1-4 alkyl)aminosulfonyl or a heterocycles selected from the group consisting of pyrrolidinyl, pyrrolyl, dihydropyrrolyl, imidazolyl, triazolyl, piperidinyl, homopiperidinyl, piperazinyl, morpholinyl, thiomorpholinyl, 1-oxo-thiomorpholinyl, 1,1-dioxothiomorpholinyl, pyridyl and tetrahydropyridyl, wherein each of said heterocycle may optionally be substituted with oxo or C 1-6 alkyl; G is a direct bond or optionally substituted C l-10 loalkanediyl; R 1 is Ar 1 or a monocyclic or bicyclic heterocycle; one of R 2a and R 3a is C 1-6 salkyl and the other one of R 2a and R 3a is hydrogen; in case R 2a is different from hydrogen then R 2b is hydrogen or C 1-6 alkyl, and R 3b is hydrogen; in case R 3a is different from hydrogen then R 3b is hydrogen or C 1-6 alkyl, and R 2b is hydrogen; t is 1, 2 or 3; Ar 1 is phenyl or substituted phenyl; and Ar 2 is phenyl or substituted phenyl. It further concerns their preparation and compositions comprising them, as well as their use as a medicine.
    • 本发明涉及对呼吸道合胞病毒复制具有抑制活性的具有抑制活性的哌啶 - 氨基 - 苯并咪唑,其具有式(I)其前药,N-氧化物,加成盐,季胺,金属络合物和立体化学异构形式,其中Q为C1 任选被三氟甲基,C 3-7环烷基,Ar 2,羟基,C 1-4烷氧基,C 1-4烷硫基,Ar 2 - 氧基 - ,Ar 2 - 硫基 - ,Ar 2(CH 2) 羟基羰基,氨基羰基,C 1-4烷基羰基,Ar 2羰基,C 1-4烷氧基羰基,Ar 2(CH 2)n羰基,氨基羰基氧基,C 1-4烷基羰基氧基,Ar 2羰基氧基, Ar 2(CH 2)n - 羰基氧基,C 1-4烷氧基羰基(CH 2)n羟基,单或二(C 1-4烷基)氨基羰基,单或二(C 1-4烷基) - 氨基羰基氧基,氨基磺酰基,单-O-(C 1-4烷基 )氨基磺酰基或选自吡咯烷基,吡咯基,二氢吡咯基,咪唑基,三唑基,哌啶基,高哌啶基,哌嗪基,吗啉基,噻吩基 吗啉基,1-氧代 - 硫代吗啉基,1,1-二氧代硫代吗啉基,吡啶基和四氢吡啶基,其中各个杂环可以任选地被氧代或C 1-6烷基取代; G是直接键或任选取代的Cl-10的亚烷基; R 1是Ar 1或单环或双环杂环; R 2a和R 3a之一是C 1-6烷基,R 2a和R 3a中的另一个是氢; 在R 2a不同于氢的情况下,R 2b是氢或C 1-6烷基,R 3b是氢; 在R 3a不同于氢的情况下,R 3b是氢或C 1-6烷基,R 2b是氢; t为1,2或3; Ar 1是苯基或取代的苯基; 且Ar 2是苯基或取代的苯基。 它还涉及它们的制备方法和包含它们的组合物,以及它们作为药物的用途。